Cargando…

Comparative Effectiveness of Implantable Defibrillators for Asymptomatic Brugada Syndrome: A Decision‐Analytic Model

BACKGROUND: Optimal management of asymptomatic Brugada syndrome (BrS) with spontaneous type I electrocardiographic pattern is uncertain. METHODS AND RESULTS: We developed an individual‐level simulation comprising 2 000 000 average‐risk individuals with asymptomatic BrS and spontaneous type I electro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khurshid, Shaan, Chen, Wanyi, Bode, Weeranun D., Wasfy, Jason H., Chhatwal, Jagpreet, Lubitz, Steven A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475040/ https://www.ncbi.nlm.nih.gov/pubmed/34387130 http://dx.doi.org/10.1161/JAHA.121.021144

Ejemplares similares

Comparative Clinical Effectiveness of Population‐Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision‐Analytic Model
por: Khurshid, Shaan, et al.
Publicado: (2021)

Catheter Ablation for Brugada Syndrome
por: Qin, Dingxin, et al.
Publicado: (2021)

Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
por: Chen, Wanyi, et al.
Publicado: (2022)

A novel use of a subcutaneous implantable cardioverter-defibrillator algorithm to detect bradycardia
por: Markman, Timothy M., et al.
Publicado: (2021)

Prognosis after Implantation of Cardioverter-Defibrillators in Korean Patients with Brugada Syndrome
por: Son, Myoung Kyun, et al.
Publicado: (2014)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Subcutaneous implantable cardioverter-defibrillator implantation assisted by hypnotic communication in a patient with Brugada syndrome
por: Scaglione, Marco, et al.
Publicado: (2019)

General anaesthesia for insertion of an automated implantable cardioverter defibrillator in a child with Brugada and autism
por: Goraksha, Shwetal, et al.
Publicado: (2010)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention
por: Bonny, Aimé, et al.
Publicado: (2016)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
por: Kawamura, Iwanari, et al.
Publicado: (2019)

Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child
por: de Asmundis, Carlo, et al.
Publicado: (2018)

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
por: Lee, Sharen, et al.
Publicado: (2020)

Approach to the asymptomatic patients with Brugada syndrome
por: Takagi, Masahiko, et al.
Publicado: (2007)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
por: Kamakura, Tsukasa, et al.
Publicado: (2016)

A Case of Young Brugada Syndrome Patient With Implantable Cardioverter Defibrillator Complication Requiring Device Extraction and Reimplantation
por: Khan, Zahid
Publicado: (2023)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
por: Nakao, Yasuhisa, et al.
Publicado: (2020)

Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: A single center experience
por: Kharazi, A, et al.
Publicado: (2007)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
por: Ishibashi, Kohei, et al.
Publicado: (2017)

SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome
por: Makarawate, Pattarapong, et al.
Publicado: (2017)

Syncope and loss of consciousness after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: Prevalence and characteristics in long-term follow-up
por: Asada, Saori, et al.
Publicado: (2023)

Twiddler's Syndrome: An Unusual Cause of Repeated Shocks by Implantable Cardioverter-Defibrillator in an Asymptomatic Patient
por: Jabri, Ahmad, et al.
Publicado: (2019)

A tick-borne illness unmasking asymptomatic Brugada syndrome
por: Hilal, Talal, et al.
Publicado: (2015)

Open chest epicardial mapping in an asymptomatic patient with Brugada syndrome
por: Watanabe, Atsuyuki, et al.
Publicado: (2019)

Cardiac magnetic resonance findings in asymptomatic patients with Brugada syndrome
por: Jensen, Christoph J, et al.
Publicado: (2009)

Implantable loop recorders in Brugada syndrome
por: Scrocco, Chiara, et al.
Publicado: (2022)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Why should we apply ABM for decision analysis for infectious diseases?—An example for dengue interventions
por: Miksch, Florian, et al.
Publicado: (2019)

Ajmaline infusion during automated screening in Brugada syndrome and spontaneous Type 1 electrocardiogram unmasks non-suitability for subcutaneous implantable cardioverter-defibrillator
por: Özkartal, Tardu, et al.
Publicado: (2019)

Brugada syndrome in a young patient with type 1 myotonic dystrophy requiring an implantable cardioverter defibrillator for primary prevention: a case report
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2019)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

What Is the Optimal Threshold at Which to Recommend Breast Biopsy?
por: Burnside, Elizabeth S., et al.
Publicado: (2012)

Not All Brugada Electrocardiogram Patterns are Brugada Syndrome or Brugada Phenocopy
por: Xu, Grace, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2nmgf91r4rq4783jv6ocud306h